|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-3-12
|
|
pubmed:abstractText |
Rhabdomyosarcoma (RMS) in adults (age > or = 16 years) is rare, accounting for less than 3% of adult soft tissue sarcomas. There is little information describing the disease biology or clinicopathologic factors that influence survival in adults with RMS. The objective of this study was to define the factors in patients with adult RMS that predict outcome, disease progression, and survival.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
794-803
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11241248-Adolescent,
pubmed-meshheading:11241248-Adult,
pubmed-meshheading:11241248-Aged,
pubmed-meshheading:11241248-Combined Modality Therapy,
pubmed-meshheading:11241248-Female,
pubmed-meshheading:11241248-Humans,
pubmed-meshheading:11241248-Male,
pubmed-meshheading:11241248-Middle Aged,
pubmed-meshheading:11241248-Neoplasm Metastasis,
pubmed-meshheading:11241248-Prognosis,
pubmed-meshheading:11241248-Proportional Hazards Models,
pubmed-meshheading:11241248-Rhabdomyosarcoma,
pubmed-meshheading:11241248-Survival Analysis
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Clinicopathologic analysis of patients with adult rhabdomyosarcoma.
|
|
pubmed:affiliation |
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
